Company record
Bioporto Diagnostics A/S
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Bioporto Diagnostics A/S.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Aug 19 | Class II | Bioporto Diagnostics A/S Device |
ProNephro AKI (NGAL) Reagent Kit (100 tests). IVD Acute Kidney Injury Test System. The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users. |